HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L6. Eosinophilic granulomatosis with polyangiitis: future therapies.

AuthorsFrank Moosig
JournalPresse medicale (Paris, France : 1983) (Presse Med) Vol. 42 Issue 4 Pt 2 Pg. 510-2 (Apr 2013) ISSN: 2213-0276 [Electronic] France
PMID23453508 (Publication Type: Journal Article, Review)
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Glucocorticoids
  • Immunologic Factors
  • Immunosuppressive Agents
  • Interleukin-5
  • Rituximab
  • Cyclophosphamide
  • mepolizumab
Topics
  • Antibodies, Antineutrophil Cytoplasmic (blood)
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Antibodies, Monoclonal, Murine-Derived (adverse effects, therapeutic use)
  • Churg-Strauss Syndrome (classification, diagnosis, drug therapy, immunology)
  • Cyclophosphamide (therapeutic use)
  • Forecasting
  • Glucocorticoids (therapeutic use)
  • Humans
  • Hypereosinophilic Syndrome (classification, diagnosis, drug therapy, immunology)
  • Immunologic Factors (therapeutic use)
  • Immunosuppressive Agents (therapeutic use)
  • Interleukin-5 (antagonists & inhibitors)
  • Randomized Controlled Trials as Topic
  • Rituximab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: